BI Receives European Commission Approval for Aservo EquiHaler

This week, the European Commission granted marketing authorization to Boehringer Ingelheim for the new Aservo® EquiHaler® for horses that suffer from severe equine asthma.

Horses with severe equine asthma struggle to breath, even at rest. iStock/Ozersahin

Horses with severe equine asthma struggle to breath, even at rest. This week, the European Commission granted marketing authorization(1) to Boehringer Ingelheim for the new Aservo® EquiHaler®, and horses that suffer from severe equine asthma can now benefit from this new therapy.

While inhaled therapies for the treatment of asthma are common in human health, the approval of the Aservo EquiHaler marks an industry first in equine medicine, as until now, there has been no approved inhalant therapy licensed for use in horses with severe equine asthma.

The Aservo EquiHaler represents the culmination of over a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. The Respimat inhaler used in human respiratory disease is differentiated by the unique Soft Mist Technology, which was integrated into the new Aservo EquiHaler, allowing medication to be inhaled, deep into the lung. “The inhaler is a prime example of leveraging innovation efforts of both our businesses. This has been a strength in the past and we will expand this in the near future to further increase the delivery of innovative solutions for our patients and customers,” shares Eric Haaksma, Head of R&D, Boehringer Ingelheim Animal Health Business Unit.

The newly approved inhaler is designed specifically for use in horses. It includes an ergonomic handle and dosing lever for ease of user handling, and a nostril adaptor that fits gently inside the nostril of the horse, allowing them to easily inhale the medicated mist. The active ingredient in the Aservo EquiHaler is the prodrug ciclesonide, which is a corticosteroid that is activated directly in the lung, reducing lower airway inflammation associated with severe equine asthma.

“Treating severe equine asthma can be challenging for veterinarians and horse owners, who struggle to find safe and effective ways to help horses breath,” says Erich Schoett, Global Business Head of Equine for the Boehringer Ingelheim Animal Health Business Unit. “Bringing a new, safe and effective treatment to the market is something that we can really be proud of. It is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.”

The Aservo EquiHaler is expected to be available for veterinarians in the EU in 2020.

(1) https://ec.europa.eu/health/documents/community-register/html/v249.htm

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of almost 4 billion euros in 2018 and presence in more than 150 markets.

Across the globe, our 10,000 employees create the future of animal wellbeing through their daily work. We believe in prevention over treatment and therefore, we focus on developing innovative solutions in the field of vaccines, parasiticides and therapeutics. With a large portfolio of advanced, preventive healthcare products, tools and services, we support our customers in taking care of the health of their animals.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

categories
tags
Trending Articles
Portrait Of Female Vet In Field With Horse
Veterinary Sustainability: Clinics Get Creative With Equine Emergency Coverage 
Showjumping of horse and rider jumping
Disease Du Jour: Role of the Permitted Treating Veterinarian 
Female Vet Examining Horse In Field With Owner
Veterinary Wellness Briefs: Setting Boundaries with Clients in Equine Practice 
madigan-foal-compression-1-min
Madigan Foal Squeeze Technique
Newsletter
Get the best from EquiManagement delivered straight to your inbox once a week! Topics include horse care, disease alerts, and vet practitioner updates.

"*" indicates required fields

Name*
Country*

Additional Offers

Untitled
This field is for validation purposes and should be left unchanged.